A payline is the percentile-rank (or, less commonly, priority-score) threshold a National Institutes of Health institute or center uses as a general guide to which peer-reviewed grant applications it expects to fund in a given fiscal year. The NHLBI payline is the version of this mechanism published by the National Heart, Lung, and Blood Institute. Understanding how paylines work — as a mechanism, not a fixed number — matters more than memorizing any single year’s figure, because the figure changes every fiscal year and differs by institute, mechanism, and investigator career stage.
What a payline actually is
After an NIH grant application goes through initial peer review at a study section, it receives an overall impact score, which is converted to a percentile rank relative to other applications reviewed by the same or a comparable study section over a recent review cycle. A payline is the percentile rank below which an institute generally expects to fund applications in a given research category, for a given fiscal year, absent other considerations. Applications scoring at or below the payline are typically funded; applications scoring above it typically are not, though paylines are guidelines for planning purposes rather than a guarantee in either direction.
Paylines are set independently by each of NIH’s 27 institutes and centers, not centrally by the NIH Office of the Director. Because each institute manages its own appropriated budget, its own mix of research priorities, and its own volume of applications, paylines vary significantly across institutes in any given fiscal year — there is no single “NIH payline.”
How the NHLBI payline works specifically
NHLBI publishes its funding guidance annually, typically framed as “funding and operating guidelines” for the fiscal year rather than using the word “payline” as an official institute term. NHLBI’s own published guidance states explicitly that it does not operate a strict cutoff score: funding decisions weigh the priority score and percentile from peer review alongside recommendations from the National Heart, Lung, and Blood Advisory Council and alignment with NHLBI’s strategic research priorities. In practice, however, NHLBI still publishes a specific percentile figure each fiscal year that functions as the operative guideline research administrators and investigators plan around — which is why the field continues to call it a payline even though NHLBI’s own materials describe it more cautiously as a funding guideline.
This distinction is worth sitting with: a published percentile guideline and a “strict cutoff” are not quite the same thing administratively, but for budgeting and application-strategy purposes at the department level, they function almost identically. Treat any given fiscal year’s NHLBI figure as the institute’s best current signal of where funding will land, not as a contractual guarantee.
Where NHLBI paylines differ from a raw percentile score
It’s easy to conflate three related but distinct numbers:
- Impact score — the raw score (1–9) a study section assigns an application after initial peer review.
- Percentile rank — the impact score converted to a rank relative to other applications reviewed in the same or comparable study section, over a defined recent review period. This is what appears on the summary statement.
- Payline — the institute’s own percentile threshold, set per fiscal year, that it uses as a planning guideline for which percentile ranks it expects to fund.
A percentile is assigned to an individual application at review; a payline is set by the institute independently of any single application, based on that year’s appropriation, application volume, and priorities. See CASRAI’s NIH Study Section entry for how the underlying peer-review and scoring process works.
Early Stage Investigator and other differentials
NIH institutes, NHLBI included, commonly publish a more generous payline for Early Stage Investigators (ESIs) — researchers within a defined window of their first independent research position — than for established investigators applying for the same mechanism. This reflects a standing NIH policy goal of protecting a pipeline of new R01-equivalent awards for early-career scientists rather than letting paylines alone determine who gets funded. See CASRAI’s Early Stage Investigator (ESI) entry for the eligibility window and how ESI status is determined and tracked in eRA Commons.
Institutes may also publish different paylines by mechanism (R01 vs. R21 vs. R03, for example) and, in some cases, by specific initiative or research priority area, rather than a single institute-wide number.
How and when NHLBI sets and updates its payline
NHLBI, like other NIH institutes, typically issues its funding and operating guidelines after the federal appropriation for that fiscal year is known (or, when Congress has not yet passed a final appropriation, based on continuing-resolution funding levels), and revisits the guidance as the fiscal year progresses and its actual application volume and budget become clearer. Because of this, the published payline can be conservative early in a fiscal year and adjusted later — institutes routinely note that guidelines are “subject to change” as the year unfolds. This is also why paylines should never be treated as durable across fiscal years: a payline is recalculated annually against that year’s specific appropriation and application pool, not carried forward from the prior year.
Applicants and research administrators should check NHLBI’s current operating guidelines directly for the fiscal year in question rather than relying on a remembered or previously cited figure, given how routinely these numbers move year to year and even within a year.
Why a payline is a guideline, not a guarantee, in both directions
Scoring within the published payline does not guarantee funding, and scoring outside it does not guarantee rejection. Institutes retain several mechanisms that operate independently of the payline:
- Council review — applications also go through second-level review by the institute’s advisory council, which can factor in program relevance and portfolio balance beyond the percentile alone.
- Select pay / exception pay — institutes can and do fund some applications that score outside the published payline, based on programmatic priority, when budget allows.
- Bridge and interim funding — some institutes, NHLBI among them at various points, have offered short-term bridge support to established investigators whose competing renewal scored close to, but outside, the payline, to preserve research continuity while a resubmission is prepared.
For this reason, research administrators typically advise investigators to treat the payline as a planning benchmark for resubmission and portfolio-timing decisions, not as the sole determinant of whether to expect an award. For the appeal process when a score itself (not funding availability) is disputed, see CASRAI’s guide on how to write a grant appeal letter — note that NIH’s appeal grounds are narrow and procedural (bias, conflict of interest, reviewer expertise, factual error) and do not include disagreement with a funding decision driven by the payline itself.
NHLBI FY2025 snapshot (illustrative, not durable)
The figures below are a labeled point-in-time snapshot reported for fiscal year 2025 and should not be treated as current for any other fiscal year. Always verify against NHLBI’s own current operating guidelines before using a specific number in a proposal budget or planning conversation.
- NHLBI’s standard R01 payline for FY2025 was reported at the 12th percentile.
- NHLBI’s ESI R01 payline for FY2025 was reported at the 22nd percentile — a 10-percentile-point differential favoring early-stage investigators, one of the larger ESI differentials among NIH institutes that year.
- NIH-wide, R01-equivalent success rates were reported to have declined from roughly 22% in FY2023 to an estimated 13% in FY2025, reflecting broader budget pressure across the agency that shapes how conservatively institutes set their paylines.
Frequently asked questions
Is the NHLBI payline the same every year?
No. NHLBI recalculates and republishes its funding guidance for every fiscal year based on that year’s appropriation and application volume, and the guidance can also be revised within a fiscal year. Never assume a prior year’s figure still applies.
Does NHLBI publish one payline for all grant types?
No. NHLBI, like other NIH institutes, commonly publishes separate figures by mechanism (for example, R01 versus R21) and by investigator career stage (standard versus Early Stage Investigator), rather than a single institute-wide number.
What’s the difference between a payline and a percentile score?
A percentile score is assigned to an individual application after peer review, reflecting how it ranked against comparable applications. A payline is the institute’s own threshold, set independently for the fiscal year, that it uses to guide which percentile ranks it expects to fund. See CASRAI’s NIH Study Section entry for how percentile scores are generated.
Can an application score outside the payline and still get funded?
Yes. Institutes retain discretion through council review, select-pay/exception-pay decisions, and program priority considerations, so a payline is a planning guideline rather than an automatic cutoff in either direction.
Where do I find NHLBI’s current payline?
Check NHLBI’s own current operating guidelines page directly for the fiscal year in question, since these figures are updated annually and sometimes revised mid-year as budget and application data become clearer.
